KEYTRUDA QLEX (subcutaneous pembrolizumab/berahyaluronidase) Patient Assistance Program
Don’t let the high cost of brand subcutaneous pembrolizumab disrupt your immunotherapy. We help eligible patients access Keytruda Qlex (subcutaneous pembrolizumab/berahyaluronidase) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Keytruda Qlex is the subcutaneous formulation of pembrolizumab combined with hyaluronidase enzyme (berahyaluronidase). Recently FDA-approved (2025) as an alternative to IV Keytruda — administered SC over 1–2 minutes vs IV over 30 minutes.
- Without assistance, Keytruda Qlex costs commonly run approximately $11,000–$13,500 per dose — similar to IV Keytruda.
- Through AffordMyPrescriptions, qualifying patients can access Keytruda Qlex for a flat $69.95 per month.
- Same active drug as IV Keytruda — pembrolizumab anti-PD-1 immunotherapy. SC administration improves convenience, reduces infusion center time. Indications/efficacy same as IV pembrolizumab.
What Is Keytruda Qlex Prescription Assistance Program?
Keytruda Qlex PAP for cancer patients.
Eligibility, oncology coordination.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
Pharmacy Price Comparison
- Keytruda Qlex $11,000–$13,500/dose — similar to IV Keytruda:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$13,000/dose | Save substantially |
| CVS Pharmacy | ~$13,500/dose | Save substantially |
| Walmart | ~$11,500/dose | Save substantially |
| Costco | ~$11,200/dose | Save substantially |
Specialty Pharmacy | ~$12,000/dose | Save substantially |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Keytruda Qlex Prescription Program?
PAP at no cost. Same Keytruda PAP applies to Qlex.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Keytruda Qlex:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $11,000–$13,500 per dose per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Keytruda Qlex assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Keytruda Qlex Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Keytruda Qlex :
Keytruda Qlex is subcutaneous pembrolizumab — the FDA-approved anti-PD-1 immunotherapy in convenient SC formulation. Hyaluronidase enzyme (berahyaluronidase) allows large-volume SC injection by breaking down hyaluronic acid in subcutaneous tissue. Same indications, efficacy, and safety as IV Keytruda.
How Keytruda Qlex Works:
Pembrolizumab blocks PD-1 on T-cells — releases brake on anti-tumor immunity, allowing T-cells to attack tumor cells. Approved across 30+ cancer indications.
SC formulation with hyaluronidase allows administration over 1–2 minutes vs 30-minute IV infusion. No need for IV access. Patient convenience advantage. Similar pharmacokinetics and clinical outcomes as IV based on non-inferiority trials.
Form and use:
Keytruda Qlex SC injection in thigh (or abdomen) every 3 or 6 weeks (matching IV dosing schedules). Administered by healthcare provider — not yet self-administration.
Generic availability:
No biosimilar. Keytruda Qlex is brand-only SC pembrolizumab formulation. IV Keytruda is the original. Other PD-1/PD-L1 immunotherapies (Opdivo, Tecentriq, Imfinzi, etc.) different drugs.
Warnings:
Same as IV Keytruda — immune-related adverse events affecting any organ (pneumonitis, colitis, hepatitis, endocrinopathies, nephritis, dermatologic, cardiac, neurologic). Injection-site reactions specific to SC route. Solid organ transplant rejection.
FAQ (Frequently Asked Questions)
Cost?+
Keytruda costs approximately ā$11,000–$13,500 per dose (every 3 weeks), with annual costs commonly $190,000–$235,000+. Through AffordMyPrescriptions, qualifying patients receive Keytruda at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
Qlex vs IV Keytruda?
Same active drug (pembrolizumab). Qlex SC over 1–2 min vs IV over 30 min. Same indications, efficacy, safety. Convenience advantage.
When to choose Qlex?
Patient preference for SC over IV. No need for IV access. Faster administration. Insurance coverage may differ — check both options.
Self-administration?
Not yet — Qlex administered by healthcare provider currently.
Same indications?
Yes — same FDA-approved cancer indications as IV Keytruda.
Denied?
Same Keytruda PAP applies. Alternative PD-1 (Opdivo, Libtayo) different products.
Take Control of Your Medication Costs
Keytruda Qlex offers SC convenience with same efficacy as IV Keytruda. PAP applies. Check eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.